LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,637,154 | -20.3% | 94,078 | -4.1% | 0.00% | -20.0% |
| Q2 2023 | $7,070,126 | -5.5% | 98,060 | -3.6% | 0.01% | 0.0% |
| Q1 2023 | $7,478,846 | +8.1% | 101,670 | -1.8% | 0.01% | 0.0% |
| Q4 2022 | $6,918,409 | -21.5% | 103,569 | +1.2% | 0.01% | -28.6% |
| Q3 2022 | $8,811,000 | -13.4% | 102,324 | -10.2% | 0.01% | -12.5% |
| Q2 2022 | $10,171,000 | -26.1% | 114,001 | -6.9% | 0.01% | -11.1% |
| Q1 2022 | $13,771,000 | -31.9% | 122,416 | -6.5% | 0.01% | -25.0% |
| Q4 2021 | $20,228,000 | -12.4% | 130,959 | -21.0% | 0.01% | -20.0% |
| Q3 2021 | $23,087,000 | +60.3% | 165,711 | +50.9% | 0.02% | +66.7% |
| Q2 2021 | $14,405,000 | -6.5% | 109,798 | +8.7% | 0.01% | -18.2% |
| Q1 2021 | $15,399,000 | +74.9% | 101,009 | +14.1% | 0.01% | +57.1% |
| Q4 2020 | $8,804,000 | -6.8% | 88,533 | -10.6% | 0.01% | -12.5% |
| Q3 2020 | $9,443,000 | +6.9% | 99,068 | +25.5% | 0.01% | 0.0% |
| Q2 2020 | $8,832,000 | +134.6% | 78,964 | +52.6% | 0.01% | +100.0% |
| Q1 2020 | $3,764,000 | -53.4% | 51,755 | -33.1% | 0.00% | -42.9% |
| Q4 2019 | $8,070,000 | +0.4% | 77,379 | -4.2% | 0.01% | 0.0% |
| Q3 2019 | $8,041,000 | -17.0% | 80,785 | -4.8% | 0.01% | -22.2% |
| Q2 2019 | $9,683,000 | -15.6% | 84,830 | -7.0% | 0.01% | -18.2% |
| Q1 2019 | $11,471,000 | -10.3% | 91,248 | -3.2% | 0.01% | -21.4% |
| Q4 2018 | $12,789,000 | -75.3% | 94,245 | -50.0% | 0.01% | -69.6% |
| Q3 2018 | $51,783,000 | +36.5% | 188,652 | +3.0% | 0.05% | +31.4% |
| Q2 2018 | $37,938,000 | +25.8% | 183,124 | +0.3% | 0.04% | +20.7% |
| Q1 2018 | $30,159,000 | +24.2% | 182,606 | +3.0% | 0.03% | +31.8% |
| Q4 2017 | $24,280,000 | +10.4% | 177,320 | +9.7% | 0.02% | +4.8% |
| Q3 2017 | $22,001,000 | +21.5% | 161,597 | +8.3% | 0.02% | +16.7% |
| Q2 2017 | $18,112,000 | +5.6% | 149,196 | -7.9% | 0.02% | -14.3% |
| Q1 2017 | $17,144,000 | +7.5% | 161,979 | +3.2% | 0.02% | +5.0% |
| Q4 2016 | $15,949,000 | +8.6% | 156,961 | +9.1% | 0.02% | +5.3% |
| Q3 2016 | $14,681,000 | -10.0% | 143,846 | +5.1% | 0.02% | -17.4% |
| Q2 2016 | $16,318,000 | +19.6% | 136,815 | +7.4% | 0.02% | +15.0% |
| Q1 2016 | $13,643,000 | +2.7% | 127,403 | +4.0% | 0.02% | 0.0% |
| Q4 2015 | $13,279,000 | +32.8% | 122,475 | +4.9% | 0.02% | +25.0% |
| Q3 2015 | $10,001,000 | -11.5% | 116,768 | +4.2% | 0.02% | -5.9% |
| Q2 2015 | $11,305,000 | +28.4% | 112,045 | -1.8% | 0.02% | +30.8% |
| Q1 2015 | $8,803,000 | +44.9% | 114,155 | -0.0% | 0.01% | +44.4% |
| Q4 2014 | $6,076,000 | +9.5% | 114,193 | -3.3% | 0.01% | 0.0% |
| Q3 2014 | $5,549,000 | -31.7% | 118,087 | -9.5% | 0.01% | -35.7% |
| Q2 2014 | $8,127,000 | -7.4% | 130,479 | +0.0% | 0.01% | -12.5% |
| Q1 2014 | $8,776,000 | +33.8% | 130,474 | +4.7% | 0.02% | +33.3% |
| Q4 2013 | $6,557,000 | +2632.1% | 124,666 | +2144.2% | 0.01% | – |
| Q3 2013 | $240,000 | +8.6% | 5,555 | -6.1% | 0.00% | – |
| Q2 2013 | $221,000 | – | 5,919 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |